These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24738068)

  • 1. A systematic follow-up of Mycobacterium tuberculosis drug-resistance and associated genotypic lineages in the French Departments of the Americas over a seventeen-year period.
    Millet J; Streit E; Berchel M; Bomer AG; Schuster F; Paasch D; Vanhomwegen J; Cadelis G; Rastogi N
    Biomed Res Int; 2014; 2014():689852. PubMed ID: 24738068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to first-line drugs and major genotypic lineages of Mycobacterium tuberculosis in the 3 French Department of the Americas: Profiles, evolution, and trends (1995-2011)].
    Millet J; Berchel M; Prudenté F; Streit E; Bomer AG; Schuster F; Vanhomwegen J; Paasch D; Galbert I; Valery E; Aga R; Rastogi N
    Bull Soc Pathol Exot; 2014 May; 107(2):90-105. PubMed ID: 24627041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.
    Jagielski T; Augustynowicz-Kopec E; Zozio T; Rastogi N; Zwolska Z
    J Clin Microbiol; 2010 Nov; 48(11):3899-909. PubMed ID: 20810763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey.
    Kisa O; Tarhan G; Gunal S; Albay A; Durmaz R; Saribas Z; Zozio T; Alp A; Ceyhan I; Tombak A; Rastogi N
    PLoS One; 2012; 7(1):e30331. PubMed ID: 22279583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
    Somphavong S; Berland JL; Gauthier M; Vu TT; Nguyen QH; Iem V; Vongvichit P; Inthavong D; Akkhavong V; Chanthavilay P; Soundala S; Keovichit I; Paranhos-Baccalà G; Paboriboune P; Nguyen TVA; Bañuls AL
    BMC Infect Dis; 2019 Oct; 19(1):851. PubMed ID: 31615439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam.
    Nguyen VA; Bañuls AL; Tran TH; Pham KL; Nguyen TS; Nguyen HV; Nguyen NL; Nguyen NL; Dang DA; Marks GB; Choisy M
    BMC Microbiol; 2016 Jul; 16(1):167. PubMed ID: 27464737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
    Dantas NG; Suffys PN; Carvalho Wda S; Gomes HM; de Almeida IN; de Assis LJ; Augusto CJ; Gomgnimbou MK; Refregier G; Sola C; de Miranda SS
    BMC Infect Dis; 2015 Aug; 15():306. PubMed ID: 26231661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
    Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
    Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.
    Mokrousov I; Vyazovaya A; Solovieva N; Sunchalina T; Markelov Y; Chernyaeva E; Melnikova N; Dogonadze M; Starkova D; Vasilieva N; Gerasimova A; Kononenko Y; Zhuravlev V; Narvskaya O
    BMC Microbiol; 2015 Dec; 15():279. PubMed ID: 26679959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach.
    Garzelli C; Lari N; Cuccu B; Tortoli E; Rindi L
    Clin Microbiol Infect; 2010 Nov; 16(11):1691-7. PubMed ID: 20041892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High clustering rates of multidrug-resistant Mycobacterium tuberculosis genotypes in Panama.
    Rosas S; Bravo J; Gonzalez F; de Moreno N; Sanchez J; Gavilan RG; Goodridge A
    BMC Infect Dis; 2013 Sep; 13():442. PubMed ID: 24053690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil.
    Salvato RS; Schiefelbein S; Barcellos RB; Praetzel BM; Anusca IS; Esteves LS; Halon ML; Unis G; Dias CF; Miranda SS; de Almeida IN; de Assis Figueredo LJ; Silva EC; Kritski AL; Dalla Costa ER; Rossetti MLR
    Epidemiol Infect; 2019 Jan; 147():e216. PubMed ID: 31364547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru.
    Barletta F; Otero L; Collantes J; Asto B; de Jong BC; Seas C; Rigouts L
    BMC Infect Dis; 2013 Aug; 13():397. PubMed ID: 23984854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan.
    Tanveer M; Hasan Z; Siddiqui AR; Ali A; Kanji A; Ghebremicheal S; Hasan R
    BMC Infect Dis; 2008 Dec; 8():171. PubMed ID: 19108722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia.
    Niemann S; Diel R; Khechinashvili G; Gegia M; Mdivani N; Tang YW
    J Clin Microbiol; 2010 Oct; 48(10):3544-50. PubMed ID: 20702677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.